Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dlICSINCT06719817
Evaluation of Some Trace Elements in Follicular Fluid in ICSI Cases and Their Effect on ICSI Outcomes
An observational study of Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl and Trace Elements in ICSI Cases, run by Assiut University at 2 sites in Egypt.
Trial summary
To evaluate concentrations of some trace elements in the follicular fluid and their reproductive outcomes. Read more about this study
- Who is it for?
- Ages 25 to 40 years, women only
- Conditions the study is for
- Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl, Trace Elements in ICSI Cases
- How many people
- 154 participants
- Where
- 2 sitesEgypt
- Study dates
- 24 Nov 2024to 20 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 40 years
- Women only
- No healthy volunteers
- Adult
Study population: good responders according to NICE guidelines with AMH more than 0.8ng/dl and antral follicular count more than 4
Inclusion Criteria:good responders according to NICE guidelines with AMH more than 0.8ng/dl and antral follicular count more than 4 Exclusion Criteria:Poor responders according to ESHRE guidelines as advanced maternal age poor ovarian response and according to NICE guidelines AMH less than 0.8ng/dl
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt2 sites, 2 recruiting
- Recruiting
Faculty of medicine
Asyut, Egypt
Ahmed Nabil Hassan, 01224532883
- Recruiting
Faculty of medicine
Asyut, Egypt
Ahmed Mohammed Nasr, Prof, 01012588888
About this study
Official title: Evaluation of Some Trace Elements in Follicular Fluid in Intracytoplasmic Sperm Injection(ICSI) Patients
To evaluate concentrations of some trace elements in the follicular fluid and their reproductive outcomes.
Read the detailed description
To evaluate some trace elements in the follicular fluid and their reproductive outcome
What is being measured
The primary outcome is the main question the study is designed to answer.
oocyte maturity
Millimetres
Measured: 2024 to 2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Dec 2024
- Study start24 Nov 2024
- Primary completion20 Aug 2026 (estimated)
- Study completion20 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dlStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 154 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fatma Ahmed Saad Waley, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06719817
- Sponsor's protocol ID
- AssiutU WHH
- Acronym
- ICSI
- Status last verified
- Dec 2024
- First submitted
- 18 Oct 2024
- Last updated
- 6 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Some Trace Elements in Follicular Fluid in Intracytoplasmic Sperm Injection(ICSI) Patients
- ClinicalTrials.gov ID
- NCT06719817
- Acronym / sponsor ID
- ICSI / AssiutU WHH
- Conditions
- Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl, Trace Elements in ICSI Cases
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 154 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 24 Nov 2024 (actual)
- Primary completion
- 20 Aug 2026 (estimated)
- Study completion
- 20 Sep 2026 (estimated)
- First posted
- 6 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate concentrations of some trace elements in the follicular fluid and their reproductive outcomes.
Detailed description
To evaluate some trace elements in the follicular fluid and their reproductive outcome
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 25 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- good responders according to NICE guidelines with AMH more than 0.8ng/dl and antral follicular count more than 4
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
oocyte maturity
Time frame: 2024 to 2026
Millimetres
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Dec 2024.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl and Trace Elements in ICSI Cases, run by Assiut University at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Fatma Ahmed Waley (01064402617, www.fatma.waley@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
oocyte maturity (time frame: 2024 to 2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2024.